The industry’s attention still gravitates toward the legacy states. But through operators like SWADE Cannabis and its parent, BeLeaf Medical Co., Missouri has become one of the most dynamic cannabis stories in the country.
Ask most cannabis insiders which states matter, and you’ll hear the usual suspects: California. Colorado. Maybe Michigan or New York. Missouri rarely makes the first cut. That may be the industry’s biggest blind spot.
Yet on the measures that count right now—sales, stability, the ambition of the operators building there—it has quietly become one of the country’s most compelling markets, and one of the few still climbing while others stall.
Much of that story runs through a single company. SWADE Cannabis, the retail brand owned by BeLeaf Medical Co., opened in 2021 as one of Missouri’s first dispensaries and has spent the years since scaling into one of the state’s defining operators. They are vertically integrated, statewide, and built for a market that keeps maturing around it.
A Market That Keeps Setting Records
Missouri launched adult-use sales in February 2023, and the numbers since have been hard to argue with. State retailers reported a record $1.5 billion in cannabis sales in 2025, up about 4% over the year before, with adult-use purchases making up nearly 90% of the total, according to the Missouri Department of Health and Senior Services.
That figure lands harder in context. While several established markets contract, like how Colorado’s annual sales slid to $1.32 billion last year, and Michigan’s legal sales dropped sharply after a January tax hike, Missouri has kept growing, pushing cumulative sales past $4.9 billion since legal sales began in 2020.
Part of the state’s edge is structural. Because Amendment 3 wrote legalization directly into the Missouri constitution, operators work from a legal foundation that local or state …
Read More
Author: High Times / High Times
